Return to homepagePandemic Pact

ANTI-CoV - Identifying effective antiviral molecules to manage the disease

  • Funded by Fondation pour la Recherche Médicale
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $243,581.54

  • Funder

    Fondation pour la Recherche Médicale

  • Principal Investigator

    Jean Dubuisson

  • Research Location

    France

  • Lead Research Institution

    Centre d'Infection et d'Immunité de l'Institut Pasteur de Lille

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This project aims to identify molecules effective against Sars-CoV-2 among antiviral compounds having had or having a marketing authorization for the treatment of pathologies other than viral respiratory infections. Their effects will then be characterized and tested in different models, alone or in combination with other antivirals being evaluated.